{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:27Z","timestamp":1786985427174,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"am","delay-in-days":719,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010010","name":"Shanxi Province Science Foundation for Youths","doi-asserted-by":"publisher","award":["20210302124191"],"award-info":[{"award-number":["20210302124191"]}],"id":[{"id":"10.13039\/501100010010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["CKD\/SXMU-2024-02"],"award-info":[{"award-number":["CKD\/SXMU-2024-02"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722012"],"award-info":[{"award-number":["2022M722012"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073909"],"award-info":[{"award-number":["82073909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204222"],"award-info":[{"award-number":["82204222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmc.2024.117961","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:04:18Z","timestamp":1729245858000},"page":"117961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents"],"prefix":"10.1016","volume":"114","author":[{"given":"Ruifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117961_b0005","series-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.bmc.2024.117961_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9841-8_1","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Sagoo","year":"2020","journal-title":"Methods Mol Biol (Clifton N.J.)"},{"key":"10.1016\/j.bmc.2024.117961_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41581-020-00391-2","article-title":"SGLT2 inhibitors may offer benefit beyond diabetes","volume":"17","author":"Kang","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.bmc.2024.117961_b0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/ijms.10001","article-title":"Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention","volume":"11","author":"Wu","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bmc.2024.117961_b0025","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: clinical use in type 2 diabetes","volume":"60","author":"Sanchez-Rangel","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.bmc.2024.117961_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103571","article-title":"ent-Labdane and ent-kaurane diterpenoids from Chelonopsis odontochila with \u03b1-glucosidase inhibitory activity","volume":"95","author":"Deng","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105767","article-title":"Design, synthesis and evaluation of a series of novel long-acting dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes","volume":"123","author":"Lin","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0040","first-page":"1972","article-title":"SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"20","author":"Li","year":"2018","journal-title":"DiabetesObes Metab"},{"key":"10.1016\/j.bmc.2024.117961_b0045","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acs.jmedchem.5b00726","article-title":"Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide","volume":"58","author":"Lau","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117291","article-title":"Design, synthesis, and biological evaluation of a potential long-acting glucagon-like peptide-1 (GLP-1) analog","volume":"85","author":"Zhang","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","article-title":"Thiazolidinediones as antidiabetic agents: a critical review","volume":"77","author":"Nanjan","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0060","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.05.008","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"125","author":"Liao","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.bmc.2024.117961_b0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117961_b0070","first-page":"424","article-title":"The future of phenotypic drug discovery","volume":"28","author":"Berg","year":"2021","journal-title":"CellChem Biol"},{"key":"10.1016\/j.bmc.2024.117961_b0075","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","article-title":"Is target-based drug discovery efficient? Discovery and \u201cOff-Target\u201d mechanisms of all drugs","volume":"66","author":"Sadri","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117961_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biocel.2011.10.001","article-title":"Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis","volume":"44","author":"Jitrapakdee","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmc.2024.117961_b0090","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1021\/acs.analchem.8b05798","article-title":"Online measurement of glucose consumption from HepG2 cells using an integrated bioreactor and enzymatic assay","volume":"91","author":"Adams","year":"2019","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106235","article-title":"Coumarin-4-yl-1,2,3-triazol-4-yl-methyl-thiazolidine-2,4-diones: synthesis, glucose uptake activity and cytotoxic evaluation","volume":"130","author":"Metre","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112315","article-title":"Structure-activity relationship and hypoglycemic activity of tricyclic matrines with advantage of treating diabetic nephropathy","volume":"201","author":"Tang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejmech.2017.09.012","article-title":"Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes","volume":"140","author":"Zhou","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2011.12.028","article-title":"Synthesis and anti-protozoal activity of novel dihydropyrrolo[3,4-d][1,2,3]triazoles","volume":"48","author":"D\u00fcr\u00fcst","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0115","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1021\/jm701191z","article-title":"Cyclooxygenase-1-selective inhibitors are attractive candidates for analgesics that do not cause gastric damage. Design and in vitro\/in vivo evaluation of a benzamide-type cyclooxygenase-1 selective inhibitor","volume":"51","author":"Kakuta","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2023.108467","article-title":"Rapid identification of in vitro cell toxicity using an electrochemical membrane screening platform","volume":"153","author":"Kohl","year":"2023","journal-title":"Bioelectrochemistry (Amsterdam, Netherlands)"},{"key":"10.1016\/j.bmc.2024.117961_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J Cheminf"},{"key":"10.1016\/j.bmc.2024.117961_b0130","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12396","article-title":"Effects of ambient temperature on glucose tolerance and insulin sensitivity test outcomes in normal and obese C57 male mice","volume":"3","author":"Dudele","year":"2015","journal-title":"Physiol Rep"},{"key":"10.1016\/j.bmc.2024.117961_b0135","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s43440-020-00089-z","article-title":"In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions","volume":"72","author":"W\u00f3jcikowski","year":"2020","journal-title":"Pharm Reports: PR"},{"key":"10.1016\/j.bmc.2024.117961_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111716","article-title":"Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents","volume":"183","author":"Wang","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117961_b0145","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2010","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:56:44Z","timestamp":1762347404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624003754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"alternative-id":["S0968089624003754"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117961","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel oxazole derivatives as potential hypoglycemic agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117961"}}